Incordex CORP

Market Movers (8-K)

OTC.Pink
ICDX
Incordex CORP
8-K: Incordex Corp. Announces Change in Control and Executive Leadership Following Share Sale
Incordex Corp. sees a complete overhaul of its leadership as CEO Iurii Abramovici sells his 5,000,000 shares to Jun Lu, who will take over as CEO, CFO, President, Secretary, and Director.
Worse than expected
OTC.Pink
ICDX
Incordex CORP
8-K: Incordex Corp. Announces Change in Independent Accounting Firm
Incordex Corp. has replaced its independent accounting firm, with FRUCI & ASSOCIATES II, PLLC resigning and Boladale Lawal and Co, Chartered Accountants being appointed.

Quarterly Earnings (10-Q)

OTC.Pink
ICDX
Incordex CORP
10-Q: Incordex Corp. Reports Q3 Loss, Zero Assets Amid Leadership Change
Incordex Corp. reported a net loss for the quarter, zero total assets, and a significant decline in revenue, alongside a change in executive leadership.
Capital raise
Worse than expected
OTC.Pink
ICDX
Incordex CORP
10-Q: Incordex Corp. Faces Going Concern Doubts Amidst Revenue Drop
Incordex Corp. reported increased net income for Q2 2025 driven by debt forgiveness, despite a significant revenue decline and ongoing going concern doubts.
Capital raise
Worse than expected
OTC.Pink
ICDX
Incordex CORP
10-Q: Incordex Corp. Reports Net Income of $5,098 for Quarter Ended September 30, 2024, Despite Going Concern Concerns
Incordex Corp. reported a net income of $5,098 for the quarter ending September 30, 2024, a significant improvement from the same period last year, but faces substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
OTC.Pink
ICDX
Incordex CORP
10-Q: Incordex Corp. Reports First Revenue and Positive Net Income in Q3 2024
Incordex Corp. reports its first revenue and a net profit for the quarter ending March 31, 2024, driven by the launch of a new website and mobile application.
Better than expected
Capital raise
OTC.Pink
ICDX
Incordex CORP
10-Q: Incordex Corp. Reports First Revenue in Latest Quarterly Filing, But Going Concern Doubts Remain
Incordex Corp. reports its first revenue in the latest quarter, but the company's ability to continue as a going concern remains in doubt.
Better than expected
Capital raise

Annual Reports (10-K)

OTC.Pink
ICDX
Incordex CORP
10-K: Incordex Corp. Reports Increased Revenue but Continues to Face Going Concern Challenges in Annual 10-K Filing
Incordex Corp.'s annual 10-K filing reveals increased revenue due to a new website and mobile app launch, but the company still faces substantial doubt about its ability to continue as a going concern.
Capital raise
Worse than expected